BridgeBio Pharma, Inc. ($BBIO)
Valantine Hannah โ Director
Shares
8,671
Price
$27.36
Total Value
$237,238.56
Nearby Earnings
Feb 24, 2026
EPS:Est: -0.75
Revenue:Est: $149.07M
Transaction Details
| Insider | Valantine Hannah |
|---|---|
| Title | Director |
| Transaction Date | Mar 10, 2026 |
| Transaction Code | M Exercise/Conversion |
| Acquired/Disposed | Acquired |
| Security | Common Stock |
| Direct/Indirect | Direct |
| Filing Date | Mar 12, 2026 |
| Shares Purchased | 8,671 |
| Price per Share | $27.36 |
| Total Value | $237,238.56 |
| Shares Owned After | 16,136 |
| Derivative | No |
| Accession Number | 0001470831-26-000260 |
| Document | View SEC Filing |